PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32351894-0	2020	Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.	apatinib	21-29	epidermal growth factor receptor	Homo sapiens	66-70	
32351894-4	2020	We report a case of EGFR wild-type and ALK-negative lung adenocarcinoma patient with multiple symptomatic BMs, who received apatinib together with brain radiation therapy.	apatinib	124-132	epidermal growth factor receptor	Homo sapiens	20-24